<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33387304</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1174</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Neuromolecular medicine</Title><ISOAbbreviation>Neuromolecular Med</ISOAbbreviation></Journal><ArticleTitle>Association of Single Nucleotide Polymorphism at rs2275294 in the ZNF512B Gene with Prognosis in Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>242</StartPage><EndPage>246</EndPage><MedlinePgn>242-246</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12017-020-08634-y</ELocationID><Abstract><AbstractText>The aim of this study is to explore whether the single nucleotide polymorphism rs2275294 in the ZNF512B gene is related to the length of survival of patients with amyotrophic lateral sclerosis (ALS). This prospective study examined 212 patients with ALS, who were genotyped at the rs2275294 locus in ZNF512B using the ligase method. Genotype was compared with clinical data and survival. Kaplan-Meier survival analysis and Cox hazard regression were used to identify risk factors of shorter survival. Our results were meta-analyzed together with previous work in order to examine the potential association between the rs2275294-C allele and survival. Of the 212 patients, 166 carried the CC&#x2009;+&#x2009;CT genotype at the rs2275294 locus, while 46 carried the TT genotype. Patients with the C allele showed significantly shorter survival than those without it (34.13&#x2009;&#xb1;&#x2009;1.9 vs. 45.32&#x2009;&#xb1;&#x2009;5.7&#xa0;months, p&#x2009;=&#x2009;0.036). Cox analysis identified the C allele and time from symptom onset to diagnosis as risk factors for shorter survival. Meta-analysis of 447 patients in China and Japan confirmed the rs2275294-C allele to be an independent risk factor of shorter survival in ALS patients. The C allele at the rs2275294 locus in ZNF512B is a risk factor for shorter survival in patients with ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Jiang</LastName><ForeName>Haixia</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yang</LastName><ForeName>Baiyuan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Seventh People's Hospital of Chengdu, Chengdu, 690041, Sichuan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Geriatric Neurology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Kelu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Geriatric Neurology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yongyun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Geriatric Neurology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Geriatric Neurology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Geriatric Neurology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Sijia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yanming</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Ailan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, People's Republic of China. 879384106@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xinglong</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-5801-5211</Identifier><AffiliationInfo><Affiliation>Department of Geriatric Neurology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, People's Republic of China. yxldoc11@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuromolecular Med</MedlineTA><NlmUniqueID>101135365</NlmUniqueID><ISSNLinking>1535-1084</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C554937">ZNF512B protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057210" MajorTopicYN="N">Delayed Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008017" MajorTopicYN="N">Life Expectancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">ZNF512B gene</Keyword><Keyword MajorTopicYN="N">rs2275294</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>2</Day><Hour>12</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33387304</ArticleId><ArticleId IdType="doi">10.1007/s12017-020-08634-y</ArticleId><ArticleId IdType="pii">10.1007/s12017-020-08634-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brooks, B. R., Miller, R. G., Swash, M., &amp; Munsat, T. L. (2000). World Federation of Neurology Research Group on Motor Neuron D. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 1(5), 293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia, R., Chio, A., &amp; Traynor, B. J. (2018). Novel genes associated with amyotrophic lateral sclerosis: Diagnostic and clinical implications. The Lancet Neurology, 17(1), 94&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Day, W. A., Koishi, K., Nukuda, H., &amp; McLennan, I. S. (2005). Transforming growth factor-beta 2 causes an acute improvement in the motor performance of transgenic ALS mice. Neurobiology of Disease, 19(1&#x2013;2), 323&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2005.01.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Duque, T., Gromicho, M., Pronto-Laborinho, A. C., &amp; de Carvalho, M. (2020). Transforming growth factor-beta plasma levels and its role in amyotrophic lateral sclerosis. Medical Hypotheses, 139, 109632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109632</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins, J. P., Thompson, S. G., Deeks, J. J., &amp; Altman, D. G. (2003). Measuring inconsistency in meta-analyses. BMJ, 327(7414), 557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId></ArticleIdList></Reference><Reference><Citation>Houi, K., Kobayashi, T., Kato, S., Mochio, S., &amp; Inoue, K. (2002). Increased plasma TGF-beta1 in patients with amyotrophic lateral sclerosis. Acta Neurologica Scandinavica, 106(5), 299&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0404.2002.01301.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Iida, A., Takahashi, A., Kubo, M., Saito, S., Hosono, N., Ohnishi, Y., et al. (2011). A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese. Human Molecular Genetics, 20(18), 3684&#x2013;3692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr268</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori, P., &amp; Van Damme, P. (2020). Amyotrophic lateral sclerosis: A clinical review. European Journal of Neurology. https://doi.org/10.1111/ene.14393 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId><ArticleId IdType="pmc">7540334</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini, R., Flynn, L. L., Pitout, I. L., Fletcher, S., Wilton, S. D., &amp; Akkari, P. A. (2019). ALS genetics, mechanisms, and therapeutics: Where are we now? Frontiers in Neuroscience, 13, 1310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning, P., Yang, X., Yang, B., Zhao, Q., Huang, H., An, R., et al. (2018). Meta-analysis of the association between ZNF512B polymorphism rs2275294 and risk of amyotrophic lateral sclerosis. Neurological Sciences, 39(7), 1261&#x2013;1266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-018-3411-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowicka, N., Juranek, J., Juranek, J. K., &amp; Wojtkiewicz, J. (2019). Risk factors and emerging therapies in amyotrophic lateral sclerosis. International Journal of Molecular Sciences, 20(11), 2616.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20112616</ArticleId></ArticleIdList></Reference><Reference><Citation>Schober, A., Peterziel, H., von Bartheld, C. S., Simon, H., Krieglstein, K., &amp; Unsicker, K. (2007). GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action. Neurobiology of Disease, 25(2), 378&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2006.10.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetsuka, S., Morita, M., Iida, A., Uehara, R., Ikegawa, S., &amp; Nakano, I. (2013). ZNF512B gene is a prognostic factor in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 324(1&#x2013;2), 163&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2012.10.029</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas, G., Sinville, R., Sutton, S., Farquar, H., Hammer, R. P., Soper, S. A., et al. (2004). Capillary and microelectrophoretic separations of ligase detection reaction products produced from low-abundant point mutations in genomic DNA. Electrophoresis, 25(10&#x2013;11), 1668&#x2013;1677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/elps.200405886</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es, M. A., Van Vught, P. W., Blauw, H. M., Franke, L., Saris, C. G., Andersen, P. M., et al. (2007). ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: A genome-wide association study. The Lancet Neurology., 6(10), 869&#x2013;877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70222-3</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es, M. A., Veldink, J. H., Saris, C. G., Blauw, H. M., van Vught, P. W., Birve, A., et al. (2009). Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nature Genetics, 41(10), 1083&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.442</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng, H. J., Debray, T. P. A., Visser, A. E., van Eijk, R. P. A., Rooney, J. P. K., Calvo, A., et al. (2018). Prognosis for patients with amyotrophic lateral sclerosis: Development and validation of a personalised prediction model. The Lancet Neurology, 17(5), 423&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30089-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, B., Jiang, H., Wang, F., Li, S., Wu, C., Bao, J., et al. (2019). UNC13A variant rs12608932 is associated with increased risk of amyotrophic lateral sclerosis and reduced patient survival: A meta-analysis. Neurological Sciences, 40(11), 2293&#x2013;2302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-03951-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, X., Zhao, Q., An, R., Zheng, J., Tian, S., &amp; Xu, Y. (2015). Association of the functional SNP rs2275294 in ZNF512B with risk of amyotrophic lateral sclerosis and Parkinson&#x2019;s disease in Han Chinese. Amyotrophic Lateral Sclerosis &amp; Frontotemporal Degeneration, 17(1&#x2013;2), 142&#x2013;147.</Citation></Reference><Reference><Citation>Yang, X., Zheng, J., Tian, S., Chen, Y., An, R., Zhao, Q., et al. (2017). HLA-DRA/HLA-DRB5 polymorphism affects risk of sporadic ALS and survival in a southwest Chinese cohort. Journal of the Neurological Sciences, 373, 124&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.12.055</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, C. J., Wang, L., Mao, S. L., Zhang, Y., Song, L. L., Cai, L. Y., et al. (2018). The clinical assessment of amyotrophic lateral sclerosis patients&#x2019; prognosis by ZNF512B gene, neck flexor muscle power score and body mass index (BMI). BMC Neurology, 18(1), 211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-018-1219-9</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>